Paper177992
Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
Starr SE and 3 others. Proc Soc Exp Biol Med, 1976. Cited by 82 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection. Papers, record 177992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/177992
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Animals, Newborn | Major topic |
| Herpes Simplex | Major topic |
| Animals | |
| Antibodies, Viral | |
| BCG Vaccine | |
| Immunotherapy | |
| Macrophages | |
| Mice | |
| Mycobacterium bovis | |
| Simplexvirus | |
| Time Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04534803 | BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST) | Background |
Source ClinicalTrials.gov
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42770653 | Trained Immunity in Childhood Vaccination. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/42770653 | PubMed |
| 41605920 | Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response. | Nat Commun | 2026 | https://conductscience.org/library/papers/41605920 | PubMed |
| 41484891 | Evaluation of trained immunity as a potential strategy for a universal Streptococcus suis vaccine using immunogenic proteins in a murine model. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/41484891 | PubMed |
| 40969767 | The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses. | Front Immunol | 2025 | https://conductscience.org/library/papers/40969767 | PubMed |
| 40266109 | Efficacy of Bacille Calmette-Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40266109 | PubMed |
| 37091987 | Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns. | iScience | 2023 | https://conductscience.org/library/papers/37091987 | PubMed |
| 36482472 | The mechanisms and cross-protection of trained innate immunity. | Virol J | 2022 | https://conductscience.org/library/papers/36482472 | PubMed |
| 35891168 | Fiction and Facts about BCG Imparting Trained Immunity against COVID-19. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35891168 | PubMed |
| 35597119 | BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35597119 | PubMed |
| 34788625 | Single-cell transcriptomic profiles reveal changes associated with BCG-induced trained immunity and protective effects in circulating monocytes. | Cell Rep | 2021 | https://conductscience.org/library/papers/34788625 | PubMed |
| 34745066 | The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34745066 | PubMed |
| 34623759 | New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data. | Int J Lab Hematol | 2021 | https://conductscience.org/library/papers/34623759 | PubMed |
| 34567010 | Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19. | Front Immunol | 2021 | https://conductscience.org/library/papers/34567010 | PubMed |
| 34444386 | What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus? | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34444386 | PubMed |
| 33790587 | BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander? | Infect Drug Resist | 2021 | https://conductscience.org/library/papers/33790587 | PubMed |
| 33641831 | BCG vaccination induced protection from COVID-19. | Indian J Tuberc | 2021 | https://conductscience.org/library/papers/33641831 | PubMed |
| 33495451 | The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guérin vaccine. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/33495451 | PubMed |
| 33418320 | BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19. | Immunobiology | 2021 | https://conductscience.org/library/papers/33418320 | PubMed |
| 33403500 | Pharmacotherapeutics of SARS-CoV-2 Infections. | J Neuroimmune Pharmacol | 2021 | https://conductscience.org/library/papers/33403500 | PubMed |
| 33341119 | Coronavirus vaccine development: from SARS and MERS to COVID-19. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/33341119 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/177992
GET https://conductscience.org/api/papers/v1/177992/cited_by?page=2